Biocatalytic synthesis and antitumor activities of novel silybin acylated derivatives with dicarboxylic acids

New Biotechnology

Volumn 28, Issue 4, 2011, Pages 342-348

  Theodosiou, Eleni ^a   Loutrari, Heleni ^b   Stamatis, Haralambos ^c   Roussos, Charis ^b   Kolisis, Fragiskos N ^a  

^a NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL DONORS; ANTI-ANGIOGENIC ACTIVITY; ANTI-TUMOR ACTIVITIES; ANTI-TUMORS; ANTIPROLIFERATIVE EFFECT; BIOCATALYTIC SYNTHESIS; BIOLOGICAL FUNCTIONS; CANDIDA ANTARCTICA LIPASE B; DICARBOXYLIC ACID; MONOESTERS; NOVOZYM435; REACTION PARAMETERS; SILYBIN; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ENDOTHELIAL CELLS; ORGANIC COMPOUNDS; ORGANIC SOLVENTS; SYNTHESIS (CHEMICAL);

ACYLATION;

DICARBOXYLIC ACID DERIVATIVE; ESTER; LIPASE B; SILIBININ; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANDIDA ANTARCTICA; CATALYSIS; DRUG STRUCTURE; DRUG SYNTHESIS; LYMPHOBLASTOMA; PRIORITY JOURNAL; SOLVENT EXTRACTION;

ACETYLATION; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; DICARBOXYLIC ACIDS; HUMANS; K562 CELLS; LIPASE; SILYMARIN;

CANDIDA ANTARCTICA;

EID: 79958071587     PISSN: 18716784     EISSN: 18764347     Source Type: Journal    
DOI: 10.1016/j.nbt.2011.01.006     Document Type: Article

References (42)

1. Chu Y.F., et al. Antioxidant and antiproliferative activities of common vegetables. J. Agric. Food Chem. 2002, 50:6910-6916.
2. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J. Nutr. Biochem. 2007, 18:427-442.
3. Kroll D.J., et al. Milk thistle nomenclature: Why it matters in cancer research and pharmacokinetic studies. Integr. Cancer Ther. 2007, 6:110-119.
4. Flora K., et al. Milk thistle (Silybum marianum) for the therapy of liver disease. Am. J. Gastroenterol. 1998, 93:139-143.
5. Jacobs B.P., et al. Milk thistle for the treatment of liver disease: a systematic review and meta analysis. Am. J. Med. 2002, 113:506-515.
6. Křen V., Walterová D. Silybin and silymarin - new effects and applications. Biomed. Papers 2005, 149:29-41.
7. Křen V., et al. Chemoenzymatic preparation of silybin β-glucuronides and their biological evaluation. Drug Metab. Dispos. 2000, 28:1513-1517.
8. Kosina P., et al. Antioxidant properties of silybin glycosides. Phytotherapy 2002, 16:S33-S39.
9. Ramasamy K., Agarwal R. Multitargeted therapy of cancer by silymarin. Cancer Lett. 2008, 269:352-362.
10. Song Y., et al. Preparation and properties of a silybin-phospholipid complex. Pharmazie 2008, 63:35-42.
11. Škottová N., et al. Effect of silymarin and silibinin-phosphatidycholine complex on plasma and lipoprotein cholesterol, and oxidation of LDL in rats fed on high cholesterol diet supplemented with currant oil. Acta Univ. Palacki Olomuc. Fac. Med. 2000, 144:55-58.
12. Wu W., et al. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur. J. Pharm. Biopharm. 2006, 63:288-294.
13. Theodosiou E., et al. Enzymatic preparation of acylated derivatives of silybin in organic and ionic liquids media and evaluation of their anti-tumor proliferative activity. Biocatal. Biotransfor. 2009, 27:161-169.
14. Gong J.X., et al. Synthesis and antioxidant properties of novel silybin analogues. Chin. Chem. Lett. 2006, 17:465-468.
15. Wang F., et al. Preparation of C-23 esterified silybin derivatives and evaluation of their lipid peroxidation inhibitory and DNA protective properties. Bioorg. Med. Chem. 2009, 17:6380-6389.
16. Gažák R., et al. Antioxidant and antiviral activities of silybin fatty acid conjugates. Eur. J. Med. Chem. 2010, 45:1059-1067.
17. Figueroa-Espinoza M.C., Villeneuve P.J. Phenolic acids enzymatic lipophilization. Agric. Food Chem. 2005, 53:2779-2787.
18. Chebil L., et al. Enzymatic acylation of flavonoids. Process Biochem. 2006, 41:2237-2251.
19. Capristo E., et al. A new HPLC method for the direct analysis of triglycerides of dicarboxylic acids in biological samples. Clin. Chim. Acta 1999, 289:11-21.
20. Brearhnach A., et al. Effect of dicarboxylic acids (C6 and C9) on human choroidal melanoma in cell culture. Invest. Ophth. Vis. Sci. 1989, 30:491-498.
21. Loutrari H., et al. Mastic oil from Pistacia lentiscus var. chia inhibits growth and survival of human K562 leukemia cells and attenuates angiogenesis. Nutr. Cancer 2006, 55:86-93.
22. Zhong X., et al. Silymarin causes caspase activation and apoptosis in K562 leukemia cells through inactivation of Akt pathways. Toxicology 2006, 227:211-216.
23. Pirildar S., et al. Chemical constituents of the different parts of Colchicum baytopiorum and their cytotoxic activities on K562 and HL60 cell lines. Pharm. Biol. 2010, 32-39.
24. Suttana W., et al. Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols. Mol. Cancer 2010, 9:99.
25. Skandrani I., et al. Leaf extracts from Moricandia arvensis promote antiproliferation of human cancer cells, induce apoptosis, and enhance antioxidant activity. Anticancer Drugs 2009, 20:573-583.
26. He R., et al. Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence. Cancer Gene Ther. 2003, 10:879-886.
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
28. Otto R.T., et al. Substrate specificity of lipase B from Candida antarctica in the synthesis of arylaliphatic glycolipids. J. Mol. Catal. B: Enzym. 2000, 8:201-211.
29. Passicos E., et al. Regioselective acylation of flavonoids catalyzed by immobilized Candida antarctica lipase under reduced pressure. Biotechnol. Lett. 2004, 26:1073-1076.
30. Kontogianni A., et al. Lipase-catalyzed esterification of rutin and naringin with fatty acids of medium carbon chain. J. Mol. Catal. B: Enzym. 2003, 21:59-62.
31. Ardhaoui M., et al. Acylation of natural flavonoids using lipase of Candida antarctica as biocatalyst. J. Mol. Catal. B: Enzym. 2004, 29:63-67.
32. Gao C., et al. Novel enzymatic approach to the synthesis of flavonoid glycosides and their esters. Biotechnol. Bioeng. 2001, 71:235-243.
33. Katsoura M., et al. Effect of different reaction parameters on the lipase catalyzed selective acylation of polyhydroxylated natural compounds in ionic liquids. Process Biochem. 2007, 42:1326-1334.
34. Yang L., et al. Hydration of enzyme in nonaqueous media is consistent with solvent dependence of its activity. Biophys. J. 2004, 87:812-821.
35. Halling P.J. Biocatalysis in low-water media: understanding effects of reaction conditions. Curr. Opin. Chem. Biol. 2000, 4:74-80.
36. Katsoura M., et al. Use of ionic liquids as media for the biocatalytic preparation of flavonoid derivatives with antioxidant potency. J. Biotechnol. 2006, 123:491-503.
37. Ferrara N., et al. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
38. Eskens F.A. Angiogenesis inhibitors in clinical development: where are we now and where are we going?. Br. J. Cancer 2004, 90:1-7.
39. Cabrera M., et al. Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships. Bioorg. Med. Chem. 2007, 15:3356-3367.
40. Mellou F., et al. Biocatalytic preparation of acylated derivatives of flavonoid glucosides enhances their antioxidant and antimicrobial activity. J. Biotechnol. 2005, 16:295-304.
41. Katsoura M., et al. Efficient enzymatic preparation of hydroxycinnamates in ionic liquids enhances their antioxidant effect on lipoproteins oxidative modification. New Biotechnol. 2009, 26:83-91.
42. Lue B.M., et al. Antioxidant properties of modified rutin esters by DPPH, reducing power, iron chelation and human low density lipoprotein assays. Food Chem. 2010, 123:221-230.